메뉴 건너뛰기




Volumn 60, Issue 4, 2014, Pages 891-893

First case of drug rash eosinophilia and systemic symptoms due to boceprevir

Author keywords

Boceprevir; Drug rash eosinophilia and systemic symptoms; Hepatitis C

Indexed keywords

ALPHA2A INTERFERON; BOCEPREVIR; EMTRICITABINE; RALTEGRAVIR; RIBAVIRIN; STEROID; TENOFOVIR DISOPROXIL; ANTIVIRUS AGENT; N-(3-AMINO-1-(CYCLOBUTYLMETHYL)-2,3-DIOXOPROPYL)-3-(2-((((1,1-DIMETHYLETHYL)AMINO)CARBONYL)AMINO)-3,3-DIMETHYL-1-OXOBUTYL)-6,6-DIMETHYL-3-AZABICYCLO(3.1.0)HEXAN-2-CARBOXAMIDE; PROLINE; SERINE PROTEINASE INHIBITOR;

EID: 84896333490     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.12.008     Document Type: Article
Times cited : (10)

References (15)
  • 1
    • 84868649787 scopus 로고    scopus 로고
    • Boceprevir in chronic hepatitis C infection: A perspective review
    • A. Ascione Boceprevir in chronic hepatitis C infection: a perspective review Ther Adv Chron Dis 3 2012 113 121
    • (2012) Ther Adv Chron Dis , vol.3 , pp. 113-121
    • Ascione, A.1
  • 4
    • 77956268467 scopus 로고    scopus 로고
    • Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): An open-label, randomised, multicentre phase 2 trial
    • P.Y. Kwo, E.J. Lawitz, J. McCone, E.R. Schiff, J.M. Vierling, and D. Pound et al. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Lancet 28 2010 705 716
    • (2010) Lancet , vol.28 , pp. 705-716
    • Kwo, P.Y.1    Lawitz, E.J.2    McCone, J.3    Schiff, E.R.4    Vierling, J.M.5    Pound, D.6
  • 7
    • 84872791667 scopus 로고    scopus 로고
    • Drug reaction with eosinophilia and systemic symptoms (DRESS)
    • V. Descamps Drug reaction with eosinophilia and systemic symptoms (DRESS) Rev Prat 62 2012 1347 1352
    • (2012) Rev Prat , vol.62 , pp. 1347-1352
    • Descamps, V.1
  • 8
    • 51149088076 scopus 로고    scopus 로고
    • Severe cutaneous adverse drug reactions: A review on epidemiology, etiology, clinical manifestation and pathogenesis
    • T. Martin, and H. Li Severe cutaneous adverse drug reactions: a review on epidemiology, etiology, clinical manifestation and pathogenesis Chin Med J 121 2008 756 761
    • (2008) Chin Med J , vol.121 , pp. 756-761
    • Martin, T.1    Li, H.2
  • 9
    • 79952010199 scopus 로고    scopus 로고
    • Pharmacogenetics of cutaneous adverse drug reactions: Pharmacogenetics of cutaneous ADR
    • M. Aihara Pharmacogenetics of cutaneous adverse drug reactions: pharmacogenetics of cutaneous ADR J Dermatol 38 2011 246 254
    • (2011) J Dermatol , vol.38 , pp. 246-254
    • Aihara, M.1
  • 10
    • 66349097529 scopus 로고    scopus 로고
    • Drug-induced hypersensitivity syndrome: Clinical and biologic disease patterns in 24 patients
    • M. Ben m 'rad, S. Leclerc-Mercier, P. Blanche, N. Franck, F. Rozenberg, and Y. Fulla et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients Medicine 88 2009 131 140
    • (2009) Medicine , vol.88 , pp. 131-140
    • Ben 'Rad M, M.1    Leclerc-Mercier, S.2    Blanche, P.3    Franck, N.4    Rozenberg, F.5    Fulla, Y.6
  • 11
    • 17644375873 scopus 로고    scopus 로고
    • Clinical heterogeneity of drug hypersensitivity
    • J.-C. Roujeau Clinical heterogeneity of drug hypersensitivity Toxicology 209 2005 123 129
    • (2005) Toxicology , vol.209 , pp. 123-129
    • Roujeau, J.-C.1
  • 12
    • 58849091724 scopus 로고    scopus 로고
    • Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure
    • M. Eshki, L. Allanore, P. Musette, B. Milpied, A. Grange, and J.-C. Guillaume et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure Arch Dermatol 145 2009 67
    • (2009) Arch Dermatol , vol.145 , pp. 67
    • Eshki, M.1    Allanore, L.2    Musette, P.3    Milpied, B.4    Grange, A.5    Guillaume, J.-C.6
  • 13
    • 0027174265 scopus 로고
    • Cutaneous disease and drug reactions in HIV infection
    • S.A. Coopman, R.A. Johnson, R. Platt, and R.S. Stern Cutaneous disease and drug reactions in HIV infection N Engl J Med 328 1993 1670 1674
    • (1993) N Engl J Med , vol.328 , pp. 1670-1674
    • Coopman, S.A.1    Johnson, R.A.2    Platt, R.3    Stern, R.S.4
  • 14
    • 84876808705 scopus 로고    scopus 로고
    • Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV
    • E.S. Bayonne Kombo, and A. Gathse Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV Med Mal Infect 43 2013 134 135
    • (2013) Med Mal Infect , vol.43 , pp. 134-135
    • Bayonne Kombo, E.S.1    Gathse, A.2
  • 15
    • 84866695339 scopus 로고    scopus 로고
    • Raltegravir-induced DRESS syndrome
    • P. Loulergue, and O. Mir Raltegravir-induced DRESS syndrome Scand J Infect Dis 44 2012 802 803
    • (2012) Scand J Infect Dis , vol.44 , pp. 802-803
    • Loulergue, P.1    Mir, O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.